Home > Animal Health & Nutrition > Wildlife Health Market

Wildlife Health Market Analysis

  • Report ID: GMI11145
  • Published Date: Aug 2024
  • Report Format: PDF

Wildlife Health Market Analysis

Based on the species, the market is categorized as mammals, birds, fish, reptiles, and amphibians. The mammal’s segment is set to lead the market, accounting for the largest revenue of USD 1 billion in 2023, expecting its dominance throughout the forecast period with a CAGR of 8.8%.
 

  • The mammals segment dominated the market due to their significant role in both ecosystems and zoonotic disease transmission. Mammals, being diverse and widespread, are often at the center of wildlife health studies, as they can harbor and transmit a range of diseases to other animals and humans.
     
  • Their complex physiology and varying habitats make them key subjects for research and monitoring. Thus, the growing focus on mammals is driven by the need to manage and prevent disease outbreaks, protect biodiversity, and ensure public health, thereby fostering the segment's prominence in the market.
     
Wildlife Health Market, By Products & Services (2023)

Based on products & services, the wildlife health market is classified into pharmaceuticals, medical devices, and veterinary services. The pharmaceuticals segment holds the largest market share of 46.8% in 2023 and is expected to maintain its dominance throughout the analysis period. The pharmaceuticals segment is further categorized into drugs, vaccines, and medical additives.
 

  • Pharmaceuticals' dominance is attributed to their critical role in managing and treating diseases across various wildlife species. These pharmaceuticals are essential for controlling outbreaks, preventing disease transmission, and safeguarding the health of both wild and captive animals.
     
  • The prominence is further fueled by the growing demand for effective treatment options and preventive strategies to tackle both emerging and existing health challenges.
     
  • Moreover, ongoing innovations in veterinary medicine and the development of specialized drugs for wildlife play a significant role in the market's expansion, underscoring the importance of pharmaceuticals in supporting wildlife health.
     

Based on the end-user, the wildlife health market is segmented into wildlife rehabilitation centers, zoos and aquariums, wildlife sanctuaries, and other end-users The zoos and aquariums segment dominated the market with the highest share in 2023.
 

  • The dominance of zoos and aquariums is established by their extensive populations of terrestrial and aquatic animals, which necessitate thorough health monitoring and management.
     
  • These facilities emphasize animal welfare and disease prevention, making substantial investments in veterinary care, diagnostic equipment, and pharmaceuticals to ensure the health of their varied species.
     
  • Thus, the demand for comprehensive health programs and preventive strategies in these densely populated environments significantly boosts the need for wildlife health solutions.
     
  • Furthermore, zoos and aquariums frequently function as research hubs, providing valuable data and insights that further impact the market.
     
North America Wildlife Health Market, 2021 – 2032 (USD Million)

U.S. dominated the North American wildlife health market accounting for USD 921.3 million in 2023 and is expected to show considerable growth over the analysis period.
 

  • The U.S. leads the market due to its extensive resources, advanced research capabilities, and substantial investments from federal agencies like the U.S. Fish and Wildlife Service and the Centers for Disease Control and Prevention (CDC), which drive significant funding and research.
     
  • Additionally, the U.S. benefits from a robust network of veterinary institutions dedicated to protecting wild animals and focusing on their welfare.
     
  • For instance, in August 2024, the Washington Animal Disease Diagnostic Laboratory identified the state’s first case of chronic wasting disease and is now ramping up surveillance and testing of deer populations across the region. As part of Washington State University’s College of Veterinary Medicine, the laboratory emphasizes the critical need for ongoing monitoring. The confirmation of this case highlights the urgency of regular surveillance and testing to ensure early detection and prompt action. These proactive measures are essential for effectively managing and containing the spread of chronic wasting disease, underscoring the importance of vigilant disease monitoring of wild animals.
     
  • Moreover, strong infrastructure supporting comprehensive monitoring, disease management, and conservation efforts positions the U.S. as a leader in addressing wildlife health challenges and advancing the market.
     

Germany exhibited a high growth potential in the European wildlife health market.
 

  • Germany is prominent in the European market due to its advanced research infrastructure, strong regulatory framework, and substantial investments in wildlife conservation and health initiatives.
     
  • The country benefits from a robust network of research institutions and veterinary schools that drive innovation and development in wildlife health technologies and strategies.
     
  • Germany's active role in monitoring and managing wildlife diseases, coupled with its commitment to environmental protection and biodiversity, positions it as a leader in the European market.
     
  • The country’s comprehensive approach to wildlife health enhances its influence and contributions to the region's overall wildlife health efforts.
     

The Asia Pacific wildlife health market is poised for rapid growth with a CAGR of 9.4% during the forecast period.
 

  • The region's growth is anticipated due to increasing investments in wildlife conservation, raising awareness of zoonotic diseases, and expanding research initiatives.
     
  • For instance, in March 2024, Reliance Industries, unveiled 'Vantara,' an ambitious wildlife preservation project set to become the world's largest zoo and rehabilitation center. Located within Reliance's Jamnagar Refinery Complex, the facility serves as a sanctuary for abused, injured, and endangered animals. The project aims to partner with renowned organizations like the International Union for Conservation of Nature (IUCN) and the World Wildlife Fund (WWF), showcasing a strong commitment to wildlife conservation. This initiative underscores the dedication to enhancing global wildlife protection efforts and strengthening the wildlife health industry in Asia.
     
  • Furthermore, growing support from governments for wildlife protection and health programs is fueling market expansion.
     
  • Therefore, the region's diverse ecosystems and large wildlife populations further contribute to the anticipated growth in wildlife health solutions.
     
Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The wildlife health industry size was valued at USD 2.3 billion in 2023 and is estimated to grow at 8.9% CAGR from 2024 to 2032, due to increasing awareness of zoonotic diseases that can spread between animals and humans.

The mammals segment accounted for USD 1 billion in 2023 and is slated to record a CAGR of 8.8% through 2032, driven by the need to manage and prevent disease outbreaks, protect biodiversity, and ensure public health.

The U.S. wildlife health market accounted for USD 921.3 million in 2023 and is expected to show considerable growth through 2032, due to its extensive resources, advanced research capabilities, and substantial investments from federal agencies.

Esaote SpA, Esco VacciXcell, Fagron, Hidrolab, Huvepharma, NexGen Pharmaceuticals, Nextech, Virbac, Telemetry solutions, and Wildlife Computers among others.

Wildlife Health Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 12
  • Tables & Figures: 294
  • Countries covered: 22
  • Pages: 170
 Download Free Sample